-
Although noninvasive positive-pressure ventilation (NPPV) has become a standard of care for acute-on-chronic ventilatory failure in patients with chronic obstructive pulmonary disease (COPD), the numerous reported studies have left uncertain how the clinician should select patients who should receive this therapy.
-
The FDA has approved the first nasally administered flu vaccine to be marketed in this country. Medimmunes FluMist is also the first influenza vaccine to use live virus.
-
The Women's Health Initiatives was halted a year ago, but fallout
from this landmark study continues. The study was designed to identify
the risks or benefits of estrogen plus progesterone vs placebo in
healthy postmenopausal women.
-
This review will provide an overview of SARS for the primary care physician, including epidemiology, etiology, review of the clinical and laboratory features as well as diagnosis, therapy, and prevention of SARS.
-
Influenza Vaccination and Reduction in Hospitalizations; Screening Men
for Prostate and Colorectal Cancer; Weight Loss in CHF and Treatment
with ACE-I; Impaired Fasting Glucose vs Impaired Glucose Tolerance;
Risk Stratification in Long-QT Syndrome; EBCT, Motivation, Behavioral
Change, and Cardiovascular Risk Profile
-
-
-
Increase in Blood Glucose Concentration During Antihypertensive Treatment as a Predictor of Myocardial Infarction; Adverse Drug Events in Ambulatory Care; Prevention of Hip Fracture by External Hip Protectors
-
Aripiprazole is a new antipsychotic agent approved for the treatment of schizophrenia. This atypical agent is a quinolinone that has partial agonist activity at dopamine D2 receptors. The drug will be marketed as being better tolerated and safer than other atypical agents, as well as being dosed once a day.
-
Cirrhosis-related parkinsonism may represent a unique, consistent, and common subset of acquired hepatocerebral degeneration, whose features are permanent and entirely different from acute hepatic encephalopathy episodes.